Efficacy and costs of combined balloon dilation plus atherectomy versus combined balloon dilation plus stent for lower-limb peripheral arterial disease: a single-center propensity-matched retrospective cohort study
Frontiers in Cardiovascular Medicine · 14.08.2026 · 13
DOI: 10.3389/fcvm.2026.1785484 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 14.08.2026. Verfasst von Haisheng Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To compare one-year vessel patency, limb perfusion and function, and direct and indirect costs between combined balloon angioplasty with rotational atherectomy versus balloon angioplasty with drug-eluting stent placement in patients with lower-limb peripheral arterial disease.
Design
Single-center retrospective cohort study.
Methods
Patients treated between January 2020 and December 2023 with atherectomy plus balloon angioplasty (AB group) were propensity-score-matched 1:1 to patients treated with balloon angioplasty plus a paclitaxel-eluting nitinol stent (BS group). The matched cohort included 160 patients per group. The primary outcome was 12-month primary vessel patency. Secondary outcomes were target vessel re-occlusion, ankle-brachial index (ABI), six-minute walk distance, Rutherford classification, disease-specific quality of life (Peripheral Artery Questionnaire, PAQ), major adverse cardiovascular events, and direct and indirect costs at one year.
Results
In the matched cohort, 12-month primary patency was similarly high in both groups. Re-occlusion rates were comparable. The adjusted between-group ABI difference at 12 months was 0.010 (95% confidence interval −0.000 to 0.019; p = 0.060). The mean 6-minute walk distance improved by 121.1 m (AB) versus 122.5 m (BS) ( p = 0.867). Rutherford category and PAQ score improved similarly in both groups (PAQ increase 25.6 vs. 26.2, p = 0.593). Major adverse cardiovascular events were rare [2 patients (1.3%) in each group by 3 months, none thereafter]. Mean total cost over one year was significantly lower in the AB group (93,189 CNY) than in the BS group (119,702 CNY; p < 0.001), driven by lower device/implant costs (27,574 vs. 54,536 CNY; p < 0.001).
Conclusions
Atherectomy plus angioplasty was associated with 12-month patency and functional outcomes for which no significant difference from balloon angioplasty with drug-eluting stenting was detected, at significantly lower one-year cost. Because the design was powered for superiority rather than non-inferiority, these findings indicate absence of evidence of a difference rather than proven equivalence. The cost difference was driven almost entirely by the lower device price of the atherectomy-based strategy. Level of evidence Therapeutic, Level III (retrospective matched cohort).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Endocrinology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- School of Public Health, Fudan University, Shanghai, China.
- Division of Population and Public Health Science, Pennington Biomedical Research Center, Baton Rouge, LA, United States.
- Department of Orthopaedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zitieren
APA
Wu, H., Xu, M., Wang, R., Shen, Y., Lu, S., & Pan, Y. (2026). Efficacy and costs of combined balloon dilation plus atherectomy versus combined balloon dilation plus stent for lower-limb peripheral arterial disease: a single-center propensity-matched retrospective cohort study. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1785484
Vancouver
Wu H, Xu M, Wang R, Shen Y, Lu S, Pan Y. Efficacy and costs of combined balloon dilation plus atherectomy versus combined balloon dilation plus stent for lower-limb peripheral arterial disease: a single-center propensity-matched retrospective cohort study. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1785484
BibTeX
@article{Wu2026,
author = {Wu, Haisheng and Xu, Manrong and Wang, Ruixin and Shen, Yun and Lu, Shengdi and Pan, Ye},
title = {Efficacy and costs of combined balloon dilation plus atherectomy versus combined balloon dilation plus stent for lower-limb peripheral arterial disease: a single-center propensity-matched retrospective cohort study},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1785484}
}
EUVIMED